An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

NCT04206813 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

352

Enrollment

OTHER

Sponsor class

Conditions

HPV Infection

Interventions

DRUG: Gardasil 9 2 dose regimen
DRUG: Gardasil 9 3 dose regimen
DRUG: Gardasil 9 rescue dose

Sponsor

Boston Medical Center

Collaborators

[object Object]